<sup>161</sup>Tb-PSMA Radioligand Therapy: First-in-Humans SPECT/CT Imaging

Akram Al‐Ibraheem, Rahma M. Doudeen, Diyaa Juaidi, Alaa Abufara, Stephan Maus

Journal of Nuclear Medicine · 2023 · 48 citations · 2 references

DOIFull text

Open access

Concepts

Abstract

Terbium-161 is a β-emitting radionuclide that resembles 177Lu in terms of its in vivo and in vitro chemical and pharmacokinetic properties, exhibiting similar behavior with regard to radioligand-specific cell uptake and internalization, as well as emitting a modest fraction of photons useful for

References

2